What happens when breakthrough epigenetics technology meets commercial urgency?
This case study reveals how a promising academic startup with cutting-edge bisulfite and methylation sequencing IP, transformed into a revenue-ready organization in record time.
PSG Life Sciences helped by:
✅ Building a commercial infrastructure from scratch
✅ Closing early strategic opportunities in diagnostics and biopharma
✅ Launching targeted campaigns with real pipeline results
✅ Winning investor confidence with institutional-grade operations
Curious how they did it, and how PSG Life Sciences helped unlock the path to scale?
👉 Download the case study to get the full story.